Transcutaneous monitoring is essential for the diagnosis and therapy guidance of chronic respiratory failure.

Patients with chronic respiratory failure (CRF) suffer from hypoxemic (type 1) or hypercapnia (type 2) failure. The combination and monitoring of SpO2 and tcPCO2 enables a distinction to be made between the two failure types and has become the standard in the diagnosis and treatment of respiratory failure.

Download the brochure to learn more about the features and benefits of Sentec transcutaneous monitoring for patients with chronic respiratory failure.

Download the brochure

Share: